ROSES25: D.3C XRISM General Observer - Type 2
Posted Dec 10
ROSES25: D.3C XRISM General Observer - Type 2
Posted Dec 10
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
$9.4M opportunity
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
$9.4M opportunity
ROSES 2025: D.2 Astrophysics Data Analysis
Posted Nov 26
100
100
50
100
100
Excellent opportunity — high volume, growing market, accessible to new entrants.